Literature DB >> 16600155

Genetic determinants of the metabolic syndrome.

Michèle M Sale1, Jonathan Woods, Barry I Freedman.   

Abstract

Complex interactions between inherited factors and the environment determine an individual's susceptibility to type 2 diabetes mellitus and related syndromes. Insulin resistance, obesity, hypertension, and hyperlipidemia frequently precede the development of frank diabetes and aggregate in families. Several genome-wide scans have recently been performed in families with this constellation of findings, called the "metabolic syndrome." These analyses strongly support an inherited component to the syndrome. In this review, we provide an overview of the evidence in support of an inherited contribution to the metabolic syndrome and the search for causative genomic regions. When multiple genome scans involving different patient cohorts implicate a common genomic region as susceptible to the metabolic syndrome, it is highly likely that causative genes reside in that area. Identification of these genes will dramatically improve our understanding of the mechanisms that underlie the metabolic syndrome, and could lead to novel treatment strategies. It is hoped that these therapies will also prevent the future development of type 2 diabetes mellitus and atherosclerotic complications, both common among individuals affected by the metabolic syndrome.

Entities:  

Mesh:

Year:  2006        PMID: 16600155     DOI: 10.1007/s11906-006-0036-5

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  50 in total

1.  Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.

Authors:  A H Kissebah; G E Sonnenberg; J Myklebust; M Goldstein; K Broman; R G James; J A Marks; G R Krakower; H J Jacob; J Weber; L Martin; J Blangero; A G Comuzzie
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Linkage analysis of a composite factor for the multiple metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study.

Authors:  Weihong Tang; Michael B Miller; Stephen S Rich; Kari E North; James S Pankow; Ingrid B Borecki; Richard H Myers; Paul N Hopkins; Mark Leppert; Donna K Arnett
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

Review 3.  Growing evidence for diabetes susceptibility genes from genome scan data.

Authors:  Mark I McCarthy
Journal:  Curr Diab Rep       Date:  2003-04       Impact factor: 4.810

4.  Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.

Authors:  J B Meigs; R B D'Agostino; P W Wilson; L A Cupples; D M Nathan; D E Singer
Journal:  Diabetes       Date:  1997-10       Impact factor: 9.461

5.  Familial clustering of insulin and abdominal visceral fat: the HERITAGE Family Study.

Authors:  Y Hong; T Rice; J Gagnon; J P Després; A Nadeau; L Pérusse; C Bouchard; A S Leon; J S Skinner; J H Wilmore; D C Rao
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

6.  Genetic and environmental architecture of the features of the insulin-resistance syndrome.

Authors:  Y Hong; N L Pedersen; K Brismar; U de Faire
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

7.  Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study.

Authors:  W Bao; S R Srinivasan; W A Wattigney; G S Berenson
Journal:  Arch Intern Med       Date:  1994-08-22

8.  The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study.

Authors:  W Chen; S R Srinivasan; A Elkasabany; G S Berenson
Journal:  Atherosclerosis       Date:  1999-07       Impact factor: 5.162

9.  Factors of insulin resistance syndrome--related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic mexican-americans.

Authors:  Rector Arya; John Blangero; Ken Williams; Laura Almasy; Thomas D Dyer; Robin J Leach; Peter O'Connell; Michael P Stern; Ravindranath Duggirala
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

10.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

View more
  5 in total

Review 1.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

2.  Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults.

Authors:  Sabrina E Noel; Chao-Qiang Lai; Josiemer Mattei; Laurence D Parnell; Jose M Ordovas; Katherine L Tucker
Journal:  Atherosclerosis       Date:  2010-02-18       Impact factor: 5.162

Review 3.  Minireview: Genome Editing of Human Pluripotent Stem Cells for Modeling Metabolic Disease.

Authors:  Haojie Yu; Chad A Cowan
Journal:  Mol Endocrinol       Date:  2016-04-13

4.  Parity and Metabolic Syndrome Risk: A Systematic Review and Meta-Analysis of 15 Observational Studies With 62,095 Women.

Authors:  Ming-Hui Sun; Zhao-Yan Wen; Ran Wang; Chang Gao; Jia-Li Yin; Yu-Jiao Chang; Qi-Jun Wu; Yu-Hong Zhao
Journal:  Front Med (Lausanne)       Date:  2022-07-12

5.  Metabolic syndrome in children (Review).

Authors:  Yue-E Wu; Chong-Lin Zhang; Qing Zhen
Journal:  Exp Ther Med       Date:  2016-08-30       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.